FGFR Inhibitors in Cholangiocarcinoma: A Real-World Experience at a Tertiary Center

Alessandro Rizzo1, Giovanni Brandi1

  • 1Alessandro Rizzo, MD, Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico "Don Tonino Bello", I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy and Giovanni Brandi, MD, PhD, Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy.

JCO Precision Oncology
|March 16, 2022
PubMed
Abstract

No abstract available in PubMed .